Euro RSCG Life LM&P Chicago Announces New Assignment from ImaRx

Wednesday, October 31, 2007 General News
Email Print This Page Comment bookmark
Font : A-A+

CHICAGO, Ill., Oct. 30 Euro RSCG Life, a leadinghealthcare communications network, is proud to announce that their Chicago-based agency has been assigned agency-of-record responsibilities for ImaRxTherapeutics Inc. (ImaRx).

Euro RSCG Life LM&P Chicago will manage the re-branding of Abbokinase(urokinase), a thrombolytic approved and marketed for the treatment of acutemassive pulmonary embolism. "It is very gratifying to see a company like ImaRxselect Euro RSCG Life LM&P as their agency of record. This is, in fact, theseventh new brand assignment for the agency in the past twelve months and weare proud to be part of building brands for companies like ImaRx," said DavidParagamian, President of Euro RSCG Life LM&P.

Skip Thurnauer, Managing Director of LM&P Chicago, will lead the agency'steam. According to Thurnauer, "ImaRx is an interesting company with acommercially available product as well as innovative pipeline technology thatpositions them favorably to be a future player in the vascular disease andstroke markets. We are excited about the opportunity to work with them at thisnascent stage of their development."

About Euro RSCG Life

Euro RSCG Life aligns the company's 44 health-focused offices in 22countries. It creates a single network with almost 1,000 employees that offersclients comprehensive communications disciplines, including advertising,public relations, event promotion, medical education, interactive marketingand consulting services. The network's client roster includes GlaxoSmithKline,Novartis, Pfizer, Sanofi-Aventis, Schering-Plough and Wyeth. Euro RSCG Life ispart of Euro RSCG Worldwide, a leading integrated marketing communicationsagency that has been recognized as 2006 "Global Agency of the Year" byAdvertising Age. Euro RSCG Worldwide is the largest unit of Havas, the world'sfourth largest communications group.

About Euro RSCG Life LM&P

Euro RSCG Life LM&P Chicago is a full-service healthcare communicationscompany particularly well-suited to work with emerging and smaller companies.The agency is a member of Euro RSCG Life, a network with 44 health-focusedoffices in 22 countries and almost 1,000 employees. Euro RSCG Life offersclients comprehensive communications disciplines, including advertising,public relations, event promotion, medical education, interactive marketingand consulting services. The network's client roster includes GlaxoSmithKline,Novartis, Pfizer, Sanofi-Aventis, Schering-Plough, and Wyeth. Euro RSCG Lifeis part of Euro RSCG Worldwide, a leading integrated marketing communicationsagency that has been recognized as 2006 "Global Agency of the Year" byAdvertising Age. Euro RSCG Worldwide is the largest unit of Havas, the world'sfourth largest communications group.

About ImaRx Therapeutics

ImaRx Therapeutics is a biopharmaceutical company developing andcommercializing therapies for vascular disorders. The company's research anddevelopment efforts are focused on therapies for stroke and other vasculardisorders using its proprietary microbubble technology. ImaRx Therapeutics'commercialization efforts are currently focused on its product, Abbokinase(R)for the treatment of acute massive pulmonary embolism.

Contact: Laura Sturtz of Euro RSCG Worldwide PR, 212-367-6870

SOURCE Euro RSCG Life LM&P


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Find a Doctor
Advertisement

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook